NASDAQ: SBFM 👥 Enters Into A Collaboration Agreement For Its K1.1 Anticancer mRNA Project! 🔬 By: TheNewswire.com November 23, 2022 at 11:20 AM EST NASDAQ: SBFM) has entered into a collaboration agreement with one of North America's leading lipid nanoparticle ("LNP") formulation companies to advance the development of Sunshine Biopharma's mRNA-based anticancer macromolecule, K1.1! Learn more about this collaboration and its significance in this video! Sunshine Biopharma focuses on the research, development & commercialization of life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. Visit Sunshine Biopharma: https://sunshinebiopharma.com/ https://investors.sunshinebiopharma.com/">Contact DetailsChristine Petraglia - TraDigital IR+1 917-633-8980investors@sunshinebiopharma.comCompany Websitehttps://sunshinebiopharma.com/
NASDAQ: SBFM) has entered into a collaboration agreement with one of North America's leading lipid nanoparticle ("LNP") formulation companies to advance the development of Sunshine Biopharma's mRNA-based anticancer macromolecule, K1.1! Learn more about this collaboration and its significance in this video! Sunshine Biopharma focuses on the research, development & commercialization of life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. Visit Sunshine Biopharma: https://sunshinebiopharma.com/ https://investors.sunshinebiopharma.com/">Contact DetailsChristine Petraglia - TraDigital IR+1 917-633-8980investors@sunshinebiopharma.comCompany Websitehttps://sunshinebiopharma.com/